Fabrication of 3D Printed, Core‐and‐Shell Implants as Controlled Release Systems for Local siRNA Delivery

Abstract

AbstractThe development and clinical translation of small interfering RNA (siRNA) therapies remains challenging owing to their poor pharmacokinetics. 3D printing technology presents a great opportunity to fabricate personalized implants for local and sustained delivery of siRNA. Hydrogels can mimic the mechanical properties of tissues, avoiding the problems associated with rigid implants. Herein, a thermoresponsive composite hydrogel suitable for extrusion 3D‐printing is formulated to fabricate controlled‐release implants loaded with siRNA‐Lipofectamine RNAiMAX complexes. A hydrogel matrix mainly composed of uncharged agarose to protect siRNA from decomplexation is selected. Additionally, pluronic F127 and gelatin are added to improve the printability, degradation, and cell adhesion to the implants. To avoid exposing siRNA to thermal stress during the printing process, a core‐and‐shell design is set up for the implants in which a core of siRNA‐complexes loaded‐pluronic F127 is printed without heat and enclosed with a shell comprising the thermoresponsive composite hydrogel. The release profile of siRNA‐complexes is envisioned to be controlled by varying the printing patterns. The results reveal that the implants sustain siRNA release for one month. The intactness of the released siRNA‐complexes is proven until the eighth day. Furthermore, by changing the printing patterns, the release profiles can be tailored.